BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37606868)

  • 1. Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study.
    Liu J; Lu Y; Liu J; Liang J; Zhang Q; Li H; Zhong X; Bu H; Wang Z; Fan L; Liang P; Xie J; Wang Y; Gong J; Chen H; Dai Y; Yang L; Su X; Wang A; Xiong L; Xia H; Jiang Y; Liu Z; Peng F
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1183-1194. PubMed ID: 37606868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study.
    Qu J; Jiang J; Lv X
    BMC Infect Dis; 2020 Aug; 20(1):571. PubMed ID: 32758162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study.
    Liu J; Dong R; Zhang H; Yao S; Liu J; Yang L; Fan L; Su X; Wang A; Su Z; Ngai IK; Dai K; Jiang Y; Peng F
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 38031335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii.
    Van TT; Kim TH; Butler-Wu SM
    Clin Microbiol Infect; 2020 Oct; 26(10):1375-1379. PubMed ID: 31972318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.
    Kwizera R; Akampurira A; Kandole TK; Nielsen K; Kambugu A; Meya DB; Boulware DR; Rhein J;
    BMC Microbiol; 2017 Aug; 17(1):182. PubMed ID: 28830348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
    Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
    Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
    Wan Z; Tao R; Hui J; Liu X; Peng X; Guo Y; Zhu X; Huang Y; Zhu B
    J Neuroinflammation; 2023 Feb; 20(1):38. PubMed ID: 36793113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
    Bicanic T; Brouwer AE; Meintjes G; Rebe K; Limmathurotsakul D; Chierakul W; Teparrakkul P; Loyse A; White NJ; Wood R; Jaffar S; Harrison T
    AIDS; 2009 Mar; 23(6):701-6. PubMed ID: 19279443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.
    Temfack E; Rim JJB; Spijker R; Loyse A; Chiller T; Pappas PG; Perfect J; Sorell TC; Harrison TS; Cohen JF; Lortholary O
    Clin Infect Dis; 2021 Apr; 72(7):1268-1278. PubMed ID: 32829406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and treatment outcomes of human immunodeficiency virus-associated cryptococcal meningitis: a 2-year retrospective analysis.
    Song W; Shen YZ; Wang ZY; Qi TK; Liu L; Zhang RF; Wang JR; Tang Y; Chen J; Sun JJ; Lu HZ
    Chin Med J (Engl); 2020 Dec; 133(23):2787-2795. PubMed ID: 33273326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cryptococcal meningitis mortality among HIV negative, non-transplant patients: a single US center cohort study.
    Motoa G; Pate A; Chastain D; Mann S; Canfield GS; Franco-Paredes C; Henao-Martínez AF
    Ther Adv Infect Dis; 2020; 7():2049936120940881. PubMed ID: 32685148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
    Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
    BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
    Rhein J; Morawski BM; Hullsiek KH; Nabeta HW; Kiggundu R; Tugume L; Musubire A; Akampurira A; Smith KD; Alhadab A; Williams DA; Abassi M; Bahr NC; Velamakanni SS; Fisher J; Nielsen K; Meya DB; Boulware DR;
    Lancet Infect Dis; 2016 Jul; 16(7):809-818. PubMed ID: 26971081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of the cryptococcus count in the cerebrospinal fluid with negative cultures in two cases of serious cryptococcal meningitis].
    Ozawa T; Anezaki T; Ohara T; Sakai T; Nakano R; Isoda M; Takahashi T; Arai A; Kobayashi H; Endo M; Takano H; Kawachi I; Toyoshima Y; Takahashi H; Soma Y; Tsuji S
    No To Shinkei; 2000 Aug; 52(8):729-33. PubMed ID: 11002485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients.
    Anekthananon T; Manosuthi W; Chetchotisakd P; Kiertiburanakul S; Supparatpinyo K; Ratanasuwan W; Pappas PG; Filler SG; Kopetskie HA; Nolen TL; Kendrick AS; Larsen RA;
    Int J STD AIDS; 2011 Nov; 22(11):665-70. PubMed ID: 22096053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.